In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia

L. Catani, L. Gugliotta, G. Zauli, G. P. Bagnara, G. Antonelli, M. Mattioli Belmonte, N. Vianelli, L. Bonsi, M. A. Brunelli, S. Tura

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background. Various authors have reported the development of anti-interferon (IFN) antibodies following IFN-alpha treatment for haematological malignancies. So far the methods for detecting these antibodies have not considered the antiproliferative activity of this IFN, which is its most important property in anticancer therapy. Methods. In this in vitro study we evaluated the ability of anti-IFN alpha-2a neutralising antibodies to inhibit the antiproliferative activity of IFN alpha-2a and lymphoblastoid IFN alpha using megakaryocyte colony growth as the revelatory system. These antibodies were detected in two patients affected by essential thrombocythaemia (ET) who lost their haematological response to IFN alpha-2a, but responded to a subsequent treatment with lymphoblastoid IFN alpha. Results and Conclusion. The results show that the inhibition of megakaryotype colony growth induced by IFN alpha-2a was totally suppressed in the presence of the two ET patients' sera, whereas the inhibition induced by lymphoblastoid IFN alpha was not significantly affected. These in vitro data demonstrate the high specificity and activity of these antibodies on the antiproliferative effect of IFN alpha-2a.

Original languageEnglish
Pages (from-to)318-321
Number of pages4
JournalHaematologica
Volume77
Issue number4
Publication statusPublished - 1992

Fingerprint

Essential Thrombocythemia
Interferon-alpha
Antibodies
Therapeutics
Interferons
Megakaryocytes
Antibody Specificity
interferon alfa-2a
In Vitro Techniques
Hematologic Neoplasms
Growth
Neutralizing Antibodies
Anti-Idiotypic Antibodies

ASJC Scopus subject areas

  • Hematology

Cite this

Catani, L., Gugliotta, L., Zauli, G., Bagnara, G. P., Antonelli, G., Mattioli Belmonte, M., ... Tura, S. (1992). In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia. Haematologica, 77(4), 318-321.

In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia. / Catani, L.; Gugliotta, L.; Zauli, G.; Bagnara, G. P.; Antonelli, G.; Mattioli Belmonte, M.; Vianelli, N.; Bonsi, L.; Brunelli, M. A.; Tura, S.

In: Haematologica, Vol. 77, No. 4, 1992, p. 318-321.

Research output: Contribution to journalArticle

Catani, L, Gugliotta, L, Zauli, G, Bagnara, GP, Antonelli, G, Mattioli Belmonte, M, Vianelli, N, Bonsi, L, Brunelli, MA & Tura, S 1992, 'In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia', Haematologica, vol. 77, no. 4, pp. 318-321.
Catani L, Gugliotta L, Zauli G, Bagnara GP, Antonelli G, Mattioli Belmonte M et al. In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia. Haematologica. 1992;77(4):318-321.
Catani, L. ; Gugliotta, L. ; Zauli, G. ; Bagnara, G. P. ; Antonelli, G. ; Mattioli Belmonte, M. ; Vianelli, N. ; Bonsi, L. ; Brunelli, M. A. ; Tura, S. / In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia. In: Haematologica. 1992 ; Vol. 77, No. 4. pp. 318-321.
@article{251b428ecbc24a2dbb07f97de59c6296,
title = "In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia",
abstract = "Background. Various authors have reported the development of anti-interferon (IFN) antibodies following IFN-alpha treatment for haematological malignancies. So far the methods for detecting these antibodies have not considered the antiproliferative activity of this IFN, which is its most important property in anticancer therapy. Methods. In this in vitro study we evaluated the ability of anti-IFN alpha-2a neutralising antibodies to inhibit the antiproliferative activity of IFN alpha-2a and lymphoblastoid IFN alpha using megakaryocyte colony growth as the revelatory system. These antibodies were detected in two patients affected by essential thrombocythaemia (ET) who lost their haematological response to IFN alpha-2a, but responded to a subsequent treatment with lymphoblastoid IFN alpha. Results and Conclusion. The results show that the inhibition of megakaryotype colony growth induced by IFN alpha-2a was totally suppressed in the presence of the two ET patients' sera, whereas the inhibition induced by lymphoblastoid IFN alpha was not significantly affected. These in vitro data demonstrate the high specificity and activity of these antibodies on the antiproliferative effect of IFN alpha-2a.",
author = "L. Catani and L. Gugliotta and G. Zauli and Bagnara, {G. P.} and G. Antonelli and {Mattioli Belmonte}, M. and N. Vianelli and L. Bonsi and Brunelli, {M. A.} and S. Tura",
year = "1992",
language = "English",
volume = "77",
pages = "318--321",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "4",

}

TY - JOUR

T1 - In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia

AU - Catani, L.

AU - Gugliotta, L.

AU - Zauli, G.

AU - Bagnara, G. P.

AU - Antonelli, G.

AU - Mattioli Belmonte, M.

AU - Vianelli, N.

AU - Bonsi, L.

AU - Brunelli, M. A.

AU - Tura, S.

PY - 1992

Y1 - 1992

N2 - Background. Various authors have reported the development of anti-interferon (IFN) antibodies following IFN-alpha treatment for haematological malignancies. So far the methods for detecting these antibodies have not considered the antiproliferative activity of this IFN, which is its most important property in anticancer therapy. Methods. In this in vitro study we evaluated the ability of anti-IFN alpha-2a neutralising antibodies to inhibit the antiproliferative activity of IFN alpha-2a and lymphoblastoid IFN alpha using megakaryocyte colony growth as the revelatory system. These antibodies were detected in two patients affected by essential thrombocythaemia (ET) who lost their haematological response to IFN alpha-2a, but responded to a subsequent treatment with lymphoblastoid IFN alpha. Results and Conclusion. The results show that the inhibition of megakaryotype colony growth induced by IFN alpha-2a was totally suppressed in the presence of the two ET patients' sera, whereas the inhibition induced by lymphoblastoid IFN alpha was not significantly affected. These in vitro data demonstrate the high specificity and activity of these antibodies on the antiproliferative effect of IFN alpha-2a.

AB - Background. Various authors have reported the development of anti-interferon (IFN) antibodies following IFN-alpha treatment for haematological malignancies. So far the methods for detecting these antibodies have not considered the antiproliferative activity of this IFN, which is its most important property in anticancer therapy. Methods. In this in vitro study we evaluated the ability of anti-IFN alpha-2a neutralising antibodies to inhibit the antiproliferative activity of IFN alpha-2a and lymphoblastoid IFN alpha using megakaryocyte colony growth as the revelatory system. These antibodies were detected in two patients affected by essential thrombocythaemia (ET) who lost their haematological response to IFN alpha-2a, but responded to a subsequent treatment with lymphoblastoid IFN alpha. Results and Conclusion. The results show that the inhibition of megakaryotype colony growth induced by IFN alpha-2a was totally suppressed in the presence of the two ET patients' sera, whereas the inhibition induced by lymphoblastoid IFN alpha was not significantly affected. These in vitro data demonstrate the high specificity and activity of these antibodies on the antiproliferative effect of IFN alpha-2a.

UR - http://www.scopus.com/inward/record.url?scp=0026785699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026785699&partnerID=8YFLogxK

M3 - Article

C2 - 1427442

AN - SCOPUS:0026785699

VL - 77

SP - 318

EP - 321

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 4

ER -